Risperidone, amisulpride, and first-generation antipsychotics (FGAs) such as thioridazine, thiothixene, and haloperidol have been reported to have a high prevalence of hyperprolactinemia and an overall prolonged rise in prolactin levels. The gene discussed is PRL; the disease is hyperprolactinemia.